ScreenerNewsCompareWatchlist
VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
USBU.S. Bancorp
$63.97$99.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
USB logo

U.S. Bancorp (USB)

Valuation Overview•Is U.S. Bancorp Overvalued or Undervalued?
Full Profile →
OverviewDCF ValuationRelative ValuationEstimates
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
OverviewUpdated Jul 18, 2026

Trading in line with fair value estimates under steady-state conditions

Valuation Alignment Spectrum
Current Price$63.33
Live Exchange Feeds
DCF Intrinsic Value$63.36
+0.3% implied move
Relative Fair Value$66.17
+4.8% vs market
Analyst Price Target$69.33
+8.4% upside (49 analysts)
Market$63.33
DCF$63.36
Relative$66.17
Wall St$69.33
Current Price
$63.33Live Exchange Feeds
DCF Intrinsic Value
$63.36+0.3% implied move
Relative Fair Value
$66.17+4.8% vs market
Analyst Price Target
$69.33+8.4% upside (49 analysts)
Valuation Profile

The market is pricing the stock in line with historical averages, assuming steady-state growth.

Financial Health

Moderate quality score of 50/100, reflecting stable operating margins and manageable leverage.

Wall Street Outlook

Wall Street forecasts a balanced outlook with consensus price targets near the current price.

Company Quality

Overall Quality
50/100
RatingGrade C+
C+
Investment Read

Verdict: Average quality business weighed down by significant solvency concerns.

EdgeReliable growth supports ongoing operations.
RiskSevere deficiencies in solvency threaten the overall investment thesis.
ImplicationRequires a deep value discount to justify the risk.
Core Pillars
Profitability
60/100Strong
ROIC: 5.2% | ROE: 12.1%
Solvency Health
25/100Weak
Piotroski F-Score: 6/9
Growth Trajectory
65/100Strong
3Y ROIC Avg: 4.7% | 5Y Gross Margin Avg: 73.4%
Quality Diagnostics
Economic MoatROIC 5.2% — below cost of capital
No Moat
Cash Return QualityOCF/NI conversion: Good
1.05x
Altman Z-ScoreBankruptcy Risk: N/A
—
Piotroski F-ScoreMomentum: Moderate
6/9

Investment Narrative

Wall Street is broadly bullish, projecting solid upside with steady expected earnings growth. This is paired with healthy capital returns, anchored by a strong, well-covered dividend yield.

Wall St Estimates

Forward Valuation49 Analysts
Fwd P/E Ratio
12.3xDiscount: 12% vs trailing
Fwd EPS
$5.21Model: $5.32
Fwd PEG Ratio
1.44Fair
Fwd EV/EBITDA
15.3xForward Estimate
Implied Growth
+3.8%EPS YoY (Implied)
Model Confidence
52%Quantitative Score
Earnings Beat Rate
92%10Q Beat Streak
Analyst Rating DistributionConsensus: Buy
Buy/Strong Buy: 25Hold: 22Sell: 2

Shareholder Returns

3.7%Yield
Total Shareholder Yield
Div: 3.2%Buyback: 0.0%
Dividend — Income-focused
FCF Yield8.0%2x+ Covered
Earnings Yield7.2%E/P Inverse
Owner Yield8.4%$8.3B
Dividend Health Diagnostics
At RiskVery Safe
Safe
Payout Ratio42%
DPS (Annual)$2.04
Streak15YContender
Dividend CAGR
3Y+2.7%5Y+4.4%
Share Δ 1Y
-0.3%
Return Contribution (10Y)+40% return boost

Fundamental Analysis

Profitability & Financial Health

Fundamental Quality Synthesis

USB demonstrates strong business quality with robust profitability and healthy margins. However, this is severely offset by a highly leveraged balance sheet (Debt/EBITDA > 4.0x) and elevated financial risk.

Moat & Profitability

60
Capital Returns
3Y Avg ROIC
4.7%
5Y Avg ROE
11.8%
ROA (TTM)
1.1%
Margin Profile
5Y Avg Gross Margin
73.4%
Operating Margin
23.2%
5Y Avg Net Margin
20.1%
FCF Margin
22.1%
Income QualityOperating Cash Flow / Net Income
1.05x

Balance Sheet & Risk

25
Liquidity & Leverage
Debt/Equity
1.19
Interest Coverage
0.66x
Current Ratio
0.26
Quick Ratio
0.26
Total Cash$46.9B
Total Debt$77.9B
Net Debt$31.0B
Altman Z-Score
—Unknown
Piotroski F-Score
6/9Typical
1ROA > 0
2OCF > 0
3ROA ↑ YoY
4OCF > NI
5Leverage ↓
6Liquidity ↑
7No dilution
8Margin ↑
9Turnover ↑
Deep Dive Financials

Growth & Efficiency Synthesis

65Good

The company maintains stable top-line performance paired with stable bottom-line earnings. The company maintains healthy operational efficiency with a 23.2% operating margin.

Growth Trajectory Matrix

Growth Trend:Decelerating
Financial MetricTrend (12Q)Latest Qtr1Y Growth3Y CAGR5Y CAGR10Y CAGR
Revenue
$10.8B+0.3%——+7.3%
EBITDA
$2.9B—+9.4%——
Net Income
$1.9B+20.3%+9.2%—+2.6%
EPS (Diluted)
$1.18+21.6%+7.7%+8.5%+3.8%
Free Cash Flow
$1.3B-29.3%-27.7%+16.5%—

Margin Profile & Efficiency

Quarterly Trend HistoryCurrent TTM: 23.2%
2021Q1 2026
Historical Averages
MetricTTM3Y Avg5Y Avg10Y Avg
Gross Margin62.8%61.6%73.4%77.7%
Operating Margin23.2%19.2%25.4%28.4%
Net Margin18.0%15.3%20.1%22.6%
FCF Margin22.1%21.9%36.9%30.9%

Earnings Surprise History

Last 12 Quarters
92%EPS Beat Rate
11 / 12Quarters Beat
+4.0%Avg Surprise
50%Rev Beat Rate
Beat/Miss History
Q4'23
Q1'24
Q2'24
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26
Q2'26
Q3'26
QuarterEPS Est.EPS Act.SurpriseEPSRev
Q3'26Latest$1.28$1.35+5.5%
Q2'26$1.14$1.18+3.5%
Q1'26$1.19$1.26+5.9%
Q4'25$1.13$1.22+8.0%
Q3'25$1.07$1.11+3.7%
Q2'25$0.98$1.03+5.2%
Q1'25$1.04$1.07+2.9%
Q4'24$0.99$1.03+4.0%
EPS and revenue estimates vs actual reported figures. Green = beat, Red = miss.

Performance vs S&P 500

Total return is +43.4% (1Y), outperforming the benchmark by +27.4%

10 Years Tracked
YTD Return+20.5%Alpha: +12.4%
1Y Return+43.4%Alpha: +27.4%
Max Drawdown-16.2%1Y Max Pullback
Beta0.74vs Market Vol
RS Rating81/99Relative Strength
Beat SPY2/10Avg Alpha: -8.7%
CAGR Returns
PeriodTotal Returnvs S&P 500 (Alpha)Dividend Contribution
YTD+20.5%+12.4%—
1Y+43.4%+27.4%+4.5%
3YCAGR+21.3%+9.4%+15.5%
5YCAGR+5.6%-6.7%+17.4%
10YCAGR+6.8%-6.3%—
Positive Return Frequency7 / 10 Years (70%)
Total return includes dividends reinvested. Excess Alpha = Stock Return − S&P 500 Return. Multi-period snapshot values use Compound Annual Growth Rate (CAGR) for periods greater than 1 year. Past performance does not guarantee future results.
S&P 500 Market Context

The S&P 500 is at 30.8x trailing P/E — Expensive relative to historical averages.

View Dashboard →

Frequently Asked Questions

Quick answers to common questions about U.S. Bancorp (USB) valuation, health, and returns.

Is USB stock undervalued or overvalued?

🟡 FAIR

U.S. Bancorp is estimated to be fair under our discounted cash flow framework. relative multiples indicate the stock is Fair versus peers compared to industry peers. trading near fair value (DCF: $63.36)

Valuation

What is the fair value and price target for USB?

U.S. Bancorp has multiple valuation anchors: DCF Intrinsic Value: $63.36 | Peer Relative Fair Value: $66.17 | Wall Street Analyst Target: $69.33 (implying +8.4% upside). A convergence of these signals offers higher conviction.

Valuation

Is USB financially stable and healthy?

U.S. Bancorp displays fair financial health with a composite quality score of 50/100, supported by a Piotroski F-Score of 6/9, Return on Invested Capital (ROIC) of 5.2%.

Quality

Does USB return capital via dividends or buybacks?

U.S. Bancorp pays a 3.2% dividend yield, covered by a 42% payout ratio with 15 years of growth, supplemented by a 0.5% buyback yield.

Income

Is USB's revenue and earnings growth accelerating?

U.S. Bancorp's current growth trajectory is Decelerating. The company achieved +0.3% 1Y revenue growth and +21.6% 1Y EPS growth, compared to its 3Y revenue CAGR of N/A.

Growth

What is the Wall Street analyst consensus on USB?

Wall Street consensus is Buy based on 49 analysts, beating EPS expectations in 92% of recent quarters with a 10-quarter streak. The consensus price target represents a +8.4% change from current levels.

Estimates

What are the primary investment risks for USB?

Investment risks for U.S. Bancorp include: -16.2% 1-year max drawdown. Volatility risk is characterized by a beta of 0.74x.

Risk

Are these valuation model estimates financial advice?

No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.

Legal

Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.

Our Methodology

Institutional-grade research documentation
Relative Valuation
Peer universe construction, Monte Carlo simulation, and confidence scoring.
→
Estimates & Forecasts
Revenue CAGR blending, margin path engine, and analyst fusion logic.
→
DCF Intrinsic Value
Two-stage discounted cash flow with WACC and Gordon Growth model.
→